ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

2016156 citationsJournal Articlehybrid Open Access

Authors

Jinping Wang · Eisai (United States)

Veronika Logovinsky · Eisai (United States)

Suzanne Hendrix · TetraLogic Pharmaceuticals (United States)

Stephanie H. Stanworth · TetraLogic Pharmaceuticals (United States)

Carlos Perdomo · Eisai (United States)

Lu Xu · Eisai (United States)

Shobha Dhadda

Abstract

ADCOMS is proposed as new standard outcome for pAD and mild AD dementia trials, and is progressing in a CAMD-sponsored qualification process for use in registration trials of pAD.

Topics & Keywords

Dementia and Cognitive Impairment Research Frailty in Older Adults Diet and metabolism studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Neurology Neurosurgery & Psychiatry

Volume 87, Issue 9, pp. 993-999

DOI: 10.1136/jnnp-2015-312383

Field-Weighted Citation Impact: 9.12